Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers A Comparison of Outcomes in Patients With COVID-19

被引：6
|
作者：
Kalra, Ankur [1 ,7 ]
Hawkins, Edward S. [8 ]
Nowacki, Amy S. [2 ]
Jain, Vardhmaan [9 ]
Milinovich, Alex [2 ]
Saef, Joshua [1 ]
Thomas, George [3 ]
Gebreselassie, Surafel K. [10 ]
Karnik, Sadashiva S. [4 ]
Jehi, Lara [11 ]
Young, James B. [5 ]
Svensson, Lars G. [6 ]
Chung, Mina K. [1 ,4 ]
Mehta, Neil [5 ]
机构：
[1] Case Western Reserve Univ, Dept Cardiovasc Med, Heart Vasc & Thorac Inst, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Quantitat Hlth Sci, Lerner Res Inst, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Hypertens & Nephrol, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Dept Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[6] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Heart Vasc & Thorac Inst, Cleveland, OH 44106 USA
[7] Cleveland Clin, Akron Gen, Sect Cardiovasc Res, Heart Vasc & Thorac Dept, Cleveland, OH 44106 USA
[8] Cleveland Clin, Medina Hosp, Ctr Emergency Med West, Medina, OH USA
[9] Cleveland Clin Fdn, Dept Internal Med, 9500 Euclid Ave, Cleveland, OH 44195 USA
[10] Cleveland Clin Florida, Dept Hypertens & Nephrol, Weston, FL USA
[11] Cleveland Clin Fdn, Cleveland, OH USA
来源：
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2020年 / 13卷 / 10期
基金：
美国国家卫生研究院;
关键词：
COVID-19; mechanical ventilation; pandemic; propensity score; upregulation; ACE2;
D O I：
10.1161/CIRCOUTCOMES.120.007115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
    Pan, Michael
    Vasbinder, Alexi
    Anderson, Elizabeth
    Catalan, Toniemarie
    Shadid, Husam R.
    Berlin, Hanna
    Padalia, Kishan
    O'Hayer, Patrick
    Meloche, Chelsea
    Azam, Tariq U.
    Khaleel, Ibrahim
    Michaud, Erinleigh
    Blakely, Pennelope
    Bitar, Abbas
    Huang, Yiyuan
    Zhao, Lili
    Pop-Busui, Rodica
    Loosen, Sven H.
    Chalkias, Athanasios
    Tacke, Frank
    Giamarellos-Bourboulis, Evangelos J.
    Reiser, Jochen
    Eugen-Olsen, Jesper
    Hayek, Salim S.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (24):
  • [2] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and clinical outcomes of COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (04) : 1603 - 1604
  • [3] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Xiao-Long Li
    Tao Li
    Qi-Cong Du
    Li Yang
    Kun-Lun He
    [J]. World Journal of Clinical Cases, 2021, 9 (20) : 5462 - 5469
  • [4] COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    St John, Megan H.
    Barry, Arden R.
    [J]. CANADIAN PHARMACISTS JOURNAL, 2020, 153 (04) : 193 - 197
  • [5] Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
    Li, Xiao-Long
    Li, Tao
    Du, Qi-Cong
    Yang, Li
    He, Kun-Lun
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (20) : 5462 - 5469
  • [6] The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients
    Harky, Amer
    Chor, Cheryl Yan Ting
    Nixon, Henry
    Jeilani, Milad
    [J]. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2021, 22 (01)
  • [7] Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19
    Covino, Marcello
    De Matteis, Giuseppe
    Burzo, Maria Livia
    Santoro, Michele
    Fuorlo, Mariella
    Sabia, Luca
    Sandroni, Claudio
    Gasbarrini, Antonio
    Franceschi, Francesco
    Gambassi, Giovanni
    [J]. INTERNAL MEDICINE JOURNAL, 2020, 50 (12) : 1483 - 1491
  • [8] COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers What Is the Evidence?
    Patel, Ankit B.
    Verma, Ashish
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1769 - 1770
  • [9] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
  • [10] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)
    Mustafic, Hazrije
    Fayssoil, Abdallah
    Josseran, Loic
    Ouadahi, Mounir
    Grimaldi-Bensouda, Lamiae
    Dubourg, Olivier
    Annane, Djillali
    Mansencal, Nicolas
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 147 : 58 - 60
12345